Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development, and marketing of innovative products to improve the well-being of all Canadians.
In 2008, Novartis Canada invested more than $96 million into research and development. As a long-time sponsor of the annual CIBC Run for the Cure, Novartis Canada makes a commitment to breast cancer research and supports physician and patient awareness.
Novartis Canada employs approximately 800 people in Canada and its headquarters are located in Dorval, Quebec. It was named again one of the “50 Best in Canada” in 2009.
Cubresa has installed the first BrainPET Insert System at St. Joseph’s Health Care London, in partnership with the hospital’s research institute – Lawson Health Research Institute.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.
